Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Atypical seropositive inflammatory arthritis complicated by B-cell lymphoproliferation during methotrexate exposure: a case report.

Created on 19 Nov 2026

Authors

Tadashi Nakamura, Hitoshi Suzushima, Yasunori Matsuki

Published in

Modern rheumatology case reports. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

We report a case of an atypical rheumatoid arthritis-like disease complicated by B-cell lymphoproliferation during methotrexate exposure with coexisting familial constitutional inv(3)(p13q23). Clinical characteristics, longitudinal disease course, responses to multiple disease-modifying anti-rheumatic drugs, serial joint imaging findings, bone marrow examination, flow cytometric analysis, and cytogenetic studies of the patient and available family members were retrospectively reviewed. A 63-year-old man fulfilled classification criteria for rheumatoid arthritis but demonstrated an unusual clinical course characterized by persistent inflammation, limited articular destructive progression over 10 years, poor response to multiple disease-modifying anti-rheumatic drugs, and three separate methotrexate exposures, all associated with worsening. During the third course of methotrexate exposure, increasing serum soluble IL-2 receptor levels prompted hematological investigation, which demonstrated an indolent mature B cell lymphoproliferative disorder requiring rituximab. Both lymphoproliferative and inflammatory manifestations improved markedly. Cytogenetic analysis identified constitutional inv(3)(p13q23) in both peripheral blood and bone marrow cells. The identical inversion was also detected in an unaffected sibling, supporting a familial constitutional structural variant. Although its clinical significance remains uncertain, the finding raises the possibility that constitutional genomic variation may influence disease susceptibility or clinical phenotype. This case highlights the importance of diagnostic reassessment in seropositive inflammatory arthritis with atypical longitudinal behavior, particularly when methotrexate exposure is repeatedly associated with clinical worsening or lymphoproliferative complications. The reproducible temporal association between methotrexate exposure and clinical worsening, together with the subsequent detection of an indolent mature B-cell lymphoproliferative disorder and familial constitutional inv(3)(p13q23), raises the possibility of an association between methotrexate exposure and disease exacerbation in this patient. However, the present observation does not establish a causal relationship between methotrexate and either the inflammatory manifestations or lymphoproliferative disorder.

PMID:
43055654
Bibliographic data and abstract were imported from PubMed on 19 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement